<!DOCTYPE html>


<style>
    body{
  background: #18181B;
}

.main{
  font-family: "Noto Sans", ui-sans-serif, system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol", "Noto Color Emoji";
  color: #FDFDFD;
}

h1 {
  font-size: 2.5rem;
  color: white;
}

h3 {
  font-size: 1.5rem;
  background: #0c087c;
  padding: 10px;
  margin: 0px;
  border: 1px solid #6b7280;}

.extended-title{
  width:100%;
}

#gsk-overview{
  display:flex;
}

h4 {
  font-size: 1rem;
  background: #27272A;
  padding: 10px;
  margin: 0px;
  border-bottom: 1px solid #6b7280;
}

h2 {
  font-size: 1.5rem;
  margin-top: 3px;
  color:#000000;
}

.header{
  display: flex;
  justify-content: center;
  align-items: center;
}
.header > * {
  margin-inline: 20px;
}

.flex-row {
  display: flex;
  flex-direction: row;
  padding:10px;
  border: 1px solid #27272A;
}

.flex-row>div {
  flex: auto;
  box-sizing: border-box;
  display: flex;
  flex-direction: column;
  justify-content: center;
  align-items: center;
}

progress[value] {
  --background: #6D6D6D;
  -webkit-appearance: none;
  -moz-appearance: none;
  appearance: none;
  border: none;
  height: 4px;
  margin: 0 10px;
  border-radius: 10em;
  background: var(--background);
}

progress[value]::-webkit-progress-bar {
  border-radius: 10em;
  background: var(--background);
}

progress[value]::-webkit-progress-value {
  border-radius: 10em;
  background: var(--color);
}

progress[value]::-moz-progress-bar {
  border-radius: 10em;
  background: var(--color);
}

label {
  font-size: 20px;
  font-weight: bold;
  display: block;
  margin: 20px 0;
}

.tab {
  overflow: hidden;
  border: 1px solid #27272A;
  background-color: #27272A;
}

.tab button {
  background-color: inherit;
  float: left;
  border: none;
  outline: none;
  cursor: pointer;
  padding: 14px 16px;
  transition: 0.3s;
  color: #ffffff;
  font-size:1.2rem;
}

.tab div {
  background-color: inherit;
  float: left;
  border: none;
  outline: none;
  cursor: pointer;
  padding: 14px 16px;
  transition: 0.3s;
  color: #ffffff;
  font-size: 1.2rem;
}

.tab button:hover {
  background-color: #18181B;
}

.tab-title{
  font-size: 1.5rem;
  font-weight: bold;
  margin-bottom:-5px;
}

.tab button.active {
  background-color: #18181B;
  border-top: 1px solid #6b7280;
  border-bottom: 1px solid #18181B;
  border-left: 1px solid #6b7280;
  border-right: 1px solid #6b7280;
}

.tabcontent {
  display: none;
  padding: 6px 12px;
  background: #18181B;
  border: 1px solid #27272A;
  border-top: 1px solid #6b7280;
  margin-top: -2px;
}

#gsk-advice {
  display: flex;
  justify-content: center;
}

#gsk-metrics{
  width:100%;
}

#recommendation {
  margin-top: 20px;
  padding: 20px;
  border-radius: 10px;
  background-color: #e1ce86;
  color: #27272A;
  width:95%;
  box-shadow: 0 4px 8px 0 #000000, 0 6px 20px 0 #000000;
  font-size: 12pt;
}

.separator {
  margin: 20px 0;
}

.separator-border {
  margin: 20px 0;
  border-bottom: 1px solid #6b7280;
}

#gsk-rag{
  margin: 32px 28px;
  padding: 12px 24px;
  background-color: #111516;
}

.section-container {
  margin-bottom: 32px;
}

  .components-container {
    display: flex;
    flex-flow: row wrap;
    align-items: flex-start;
    gap: 0 32px;
  }

    .component-card {
      background-color: #14191B;
      border-radius: 16px;
      padding: 28px 32px 32px 32px;
      display: flex;
      flex-flow: column;
      align-items: center;
      margin-top: 32px;
      flex-grow: 1;
    }

    .component-title {
      font-size: 12px;
      font-weight: 500;
      color: #B1B1B1;
      padding-bottom: 8px;
    }

    .component-value {
      font-size: 32px;
      font-weight: 500;
      padding-bottom: 12px;
    }
      
      .text-green {
        color: #04B543;
      }
      
      .text-orange {
        color: #E76E0F;
      }
      
      .text-red {
        color: #EA3829;
      }

      .tooltip {
        position: relative;
        display: inline-block;
      }

      .tooltip .tooltiptext {
        visibility: hidden;
        width: 120px;
        background-color: #464646;
        color: #E6E6E6;
        text-align: center;
        border-radius: 6px;
        position: absolute;
        z-index: 1;
        top: 150%;
        left: 50%;
        margin-left: -60px;
        font-size: 12px;
        padding: 12px;
      }
      
      .tooltip .tooltiptext::after {
        content: "";
        position: absolute;
        bottom: 100%;
        left: 50%;
        margin-left: -5px;
        border-width: 5px;
        border-style: solid;
        border-color: transparent transparent black transparent;
      }
      
      .tooltip:hover .tooltiptext {
        visibility: visible;
      }

    .overall-card {
      background-color: #026836;
      border-radius: 16px;
      padding: 28px 32px 32px 32px;
      display: flex;
      flex-flow: column;
      align-items: center;
      justify-content: center;
      margin-top: 32px;
      flex-grow: 1;
    }
  
    .overall-title {
      font-size: 12px;
      font-weight: 500;
      color: #E6E6E6;
      padding: 14px 0 8px 0;
      text-transform: uppercase;
     }
  
    .overall-value {
      font-size: 32px;
      font-weight: 500;
      padding-bottom: 12px;
      color: #E6E6E6;
    }

.section-title {
  font-size: 12px;
  color: #B1B1B1;
  margin-bottom: 20px;
  text-align: left;
  width: 100%;
}

.section-content {
  color: #E6E6E6;
  font-size: 20px;
  line-height: 1.5;
}

.section-card {
  background-color: #14191B;
  border-radius: 16px;
  padding: 28px 32px 32px 32px;
  display: flex;
  flex-flow: column;
  align-items: center;
}

.correctness-indicator{
  padding: 20px;
  border-radius: 50px;
  font-size: 16pt;
  box-shadow: 0 4px 8px 0 #000000, 0 6px 20px 0 #000000;
  text-align: center;
}

.metric-title{
  margin: -2px;
  border-bottom: none;
}

.hist-row {
  display: flex;
  flex-direction: row;
  padding: 10px;
  justify-content: space-around;
  width: 85%;
}

.hist-row>div {
  flex: auto;
  box-sizing: border-box;
  display: flex;
  flex-direction: column;
  justify-content: center;
  align-items: center;
  padding-left: 1%;
  padding-right: 1%;
}

.tab-row{
  display: flex;
  flex-direction: column;
  align-items: center;
}

#component-table{
  width:50%;
  margin-top: 10px;
}

.green{
  background-color: #0a980a;
}

.orange {
  background-color: #e5b62a;
}

.red {
  background-color: #ba0e0e;
}

.progress-green {
  --color: #04B543;
}

.progress-orange {
  --color: #E76E0F;
}

.progress-red {
  --color: #EA3829;
}

.corr-plot{
  flex: 1;
  padding-left: 2%;
}

.tooltip-text {
  position: absolute;
  display: none;
  visibility: hidden;
  z-index: 1;
  top: 100%;
  left: 0%;
  width: 100%;
  color: white;
  font-size: 12px;
  background-color: #2d3d4c;
  border-radius: 10px;
  padding: 10px 15px 10px 15px;
}

#fade {
  opacity: 1;
  transition: opacity 0.5s;
}

#delay {
  opacity: 0;
  transition: opacity 0.2s;
  transition-delay: 1s;
}

td {
  position: relative;
}

tr:hover .tooltip-text {
  display: block;
  visibility: visible;
}

.tr:hover #fade {
  opacity: 1;
}

.tr:hover #delay {
  opacity: 1;
}

.callout {
  padding: 0.5rem 1rem 0.5rem 3rem;
  background: #D9EDF9;
  border: 3px solid #0088D1;
  color: #272eb5;
  position: relative;
  max-width: 40rem;
  border-radius: 10px;
  margin-top: 10%;
  font-size: 11pt;
}

.callout-icon {
  content: "";

  /* SVG via a data URI! */
  background-size: cover;
  width: 1.5rem;
  height: 1.5rem;
  display: block;
  position: absolute;
  left: 0.9rem;
  top: 1.1rem;
}

.callout-icon svg{
  fill: #016ca7;
}
.callout p+p {
  margin-top: 1em;
}

.callout a {
  color: #272eb5;
  font-weight: bold;
}

#gsk-logo {
  padding-top: 10px;
}
</style>
<script src="https://cdn.bokeh.org/bokeh/release/bokeh-3.3.4.min.js" integrity="sha384-5QIrjQuyo4I/x6DK/Sau33lcA3hT2TCZGr9vbk+2ebd7Da6FnR1amdM+9B5xOrSf" crossorigin="anonymous"></script>
<script src="https://cdn.bokeh.org/bokeh/release/bokeh-gl-3.3.4.min.js" integrity="sha384-tXTWPp/bAKa+K9RPuXh7DNvye0Mv+P+6y4rAMVy+pWapsnXg9UG7g20WZ0N4i28A" crossorigin="anonymous"></script>





<div class="main">
    <div id="gsk-rag" class="dark:text-white dark:bg-zinc-800 rounded border border-gray-500">
        <div class="header border-b border-b-gray-500">
            
                <svg xmlns="http://www.w3.org/2000/svg" width="60" height="30" viewBox="0 0 30 15" fill="none" id="gsk-logo">
                    <path fill="#fff" fill-rule="evenodd"
                        d="M22.504 1.549a4.196 4.196 0 0 1 2.573-.887v.002a3.783 3.783 0 0 1 2.706 1.086 3.783 3.783 0 0 1 1.126 2.69 3.771 3.771 0 0 1-1.126 2.69 3.77 3.77 0 0 1-2.706 1.085l-4.794.011-2.533 3.467L8.203 15l2.881-3.335a9.829 9.829 0 0 1-4.663-1.68H3.185L0 7.163h3.934C4.263 3.165 8.187 0 12.96 0c2.24 0 4.489.696 6.175 1.909a7.423 7.423 0 0 1 1.882 1.919 4.194 4.194 0 0 1 1.487-2.28ZM7.05 3.249l3.91 3.915h1.505L7.89 2.584a7.773 7.773 0 0 0-.84.665Zm4.079-2.008 5.923 5.923h1.503l-6.086-6.087c-.45.023-.898.078-1.34.164ZM4.574 8.226h-1.77l.784.693h1.584a8.454 8.454 0 0 1-.598-.693Zm9.479 0H5.984c1.469 1.477 3.656 2.377 5.977 2.422l2.092-2.422Zm-2.458 4.472 5.492-1.902 1.878-2.569h-3.508l-3.862 4.47Zm10.361-5.552h3.265a2.714 2.714 0 0 0 1.747-4.648 2.711 2.711 0 0 0-1.888-.773 3.127 3.127 0 0 0-3.123 3.124v2.297Zm3.659-3.73a.677.677 0 1 1-.134 1.348.677.677 0 0 1 .134-1.348Z"
                        clip-rule="evenodd" />
                </svg>
            <h1>RAG Evaluation Toolkit</h1>
        </div>
        
        <div class="section-container">
            <div class="components-container">
                
                <div class="component-card">
                    <div class="component-title">GENERATOR</div>
                    <div class="component-value tooltip  text-orange ">
                        68.0%
                            <span class="tooltiptext" id="fade">The Generator is the LLM inside the RAG to generate the answers.</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=68.0 class=" progress-orange ">68.0%</progress>
                    </div>
                </div>
                
                <div class="component-card">
                    <div class="component-title">RETRIEVER</div>
                    <div class="component-value tooltip  text-green ">
                        100.0%
                            <span class="tooltiptext" id="fade">The Retriever fetches relevant documents from the knowledge base according to a user query.</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=100.0 class=" progress-green ">100.0%</progress>
                    </div>
                </div>
                
                <div class="component-card">
                    <div class="component-title">REWRITER</div>
                    <div class="component-value tooltip  text-green ">
                        100.0%
                            <span class="tooltiptext" id="fade">The Rewriter modifies the user query to match a predefined format or to include the context from the chat history.</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=100.0 class=" progress-green ">100.0%</progress>
                    </div>
                </div>
                
                <div class="component-card">
                    <div class="component-title">ROUTING</div>
                    <div class="component-value tooltip  text-green ">
                        100.0%
                            <span class="tooltiptext" id="fade">The Router filters the query of the user based on his intentions (intentions detection).</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=100.0 class=" progress-green ">100.0%</progress>
                    </div>
                </div>
                
                <div class="component-card">
                    <div class="component-title">KNOWLEDGE_BASE</div>
                    <div class="component-value tooltip  text-green ">
                        74.55%
                            <span class="tooltiptext" id="fade">The knowledge base is the set of documents given to the RAG to generate the answers. Its scores is computed differently from the other components: it is the difference between the maximum and minimum correctness score across all the topics of the knowledge base.</span>
                    </div>
                    <div class="component-bar">
                        <progress max="100" value=74.54545454545453 class=" progress-green ">74.55%</progress>
                    </div>
                </div>
                
                <div class="overall-card">
                    <div class="overall-title">Overall Correctness Score</div>
                    <div class="overall-value">68%</div>
                </div>
            </div>
        </div>

        <div class="section-container">
            <div class="section-card">
                <div class="section-title">RECOMMENDATION</div>
                <span class="section-content">Focus on enhancing the knowledge base quality, particularly for Over-the-Counter and Prescription Drugs, to achieve more balanced performance across topics, and improve the Generator to better handle complex questions.</span>
            </div>
        </div>

        <div class="section-container">
            <div class="section-card">
                <div class="section-title">CORRECTNESS BY TOPIC</div>
                    <script type="text/javascript">
        (function() {
  const fn = function() {
    Bokeh.safely(function() {
      (function(root) {
        function embed_document(root) {
        const docs_json = '{"f417c8e8-62cf-4bc7-811a-28f5bfc67656":{"version":"3.4.3","title":"Bokeh Application","roots":[{"type":"object","name":"Figure","id":"p4075","attributes":{"height":350,"width_policy":"max","x_range":{"type":"object","name":"DataRange1d","id":"p4077","attributes":{"start":0}},"y_range":{"type":"object","name":"FactorRange","id":"p4084","attributes":{"factors":["Benzodiazepine Risks and Effects","Others","Over-the-Counter and Prescription Drugs"]}},"x_scale":{"type":"object","name":"LinearScale","id":"p4085"},"y_scale":{"type":"object","name":"CategoricalScale","id":"p4086"},"title":{"type":"object","name":"Title","id":"p4082","attributes":{"text_color":"#E0E0E0","text_font":"Helvetica","text_font_size":"14pt"}},"outline_line_color":"#E0E0E0","outline_line_alpha":0.25,"renderers":[{"type":"object","name":"GlyphRenderer","id":"p4104","attributes":{"data_source":{"type":"object","name":"ColumnDataSource","id":"p4072","attributes":{"selected":{"type":"object","name":"Selection","id":"p4073","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p4074"},"data":{"type":"map","entries":[["correctness",{"type":"ndarray","array":{"type":"bytes","data":"AAAAAAAAVEAAAAAAAMBSQEUXXXTRRUtA"},"shape":[3],"dtype":"float64","order":"little"}],["metadata_values",["Benzodiazepine Risks and Effects","Others","Over-the-Counter and Prescription Drugs"]],["colors",["#006837","#63bb62","#a50026"]]]}}},"view":{"type":"object","name":"CDSView","id":"p4105","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p4106"}}},"glyph":{"type":"object","name":"HBar","id":"p4101","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"#1f77b4"},"fill_color":{"type":"value","value":"#14191B"}}},"nonselection_glyph":{"type":"object","name":"HBar","id":"p4102","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"#1f77b4"},"line_alpha":{"type":"value","value":0.1},"fill_color":{"type":"value","value":"#14191B"},"fill_alpha":{"type":"value","value":0.1},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"HBar","id":"p4103","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"#1f77b4"},"line_alpha":{"type":"value","value":0.2},"fill_color":{"type":"value","value":"#14191B"},"fill_alpha":{"type":"value","value":0.2},"hatch_alpha":{"type":"value","value":0.2}}}}},{"type":"object","name":"GlyphRenderer","id":"p4113","attributes":{"data_source":{"id":"p4072"},"view":{"type":"object","name":"CDSView","id":"p4114","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p4115"}}},"glyph":{"type":"object","name":"HBar","id":"p4110","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"white"},"line_width":{"type":"value","value":2},"fill_color":{"type":"value","value":"#78BBFA"},"fill_alpha":{"type":"value","value":0.7}}},"nonselection_glyph":{"type":"object","name":"HBar","id":"p4111","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"white"},"line_alpha":{"type":"value","value":0.1},"line_width":{"type":"value","value":2},"fill_color":{"type":"value","value":"#78BBFA"},"fill_alpha":{"type":"value","value":0.1},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"HBar","id":"p4112","attributes":{"y":{"type":"field","field":"metadata_values"},"height":{"type":"value","value":0.85},"right":{"type":"field","field":"correctness"},"line_color":{"type":"value","value":"white"},"line_alpha":{"type":"value","value":0.2},"line_width":{"type":"value","value":2},"fill_color":{"type":"value","value":"#78BBFA"},"fill_alpha":{"type":"value","value":0.2},"hatch_alpha":{"type":"value","value":0.2}}}}},{"type":"object","name":"GlyphRenderer","id":"p4123","attributes":{"visible":false,"data_source":{"type":"object","name":"ColumnDataSource","id":"p4117","attributes":{"selected":{"type":"object","name":"Selection","id":"p4118","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p4119"},"data":{"type":"map","entries":[["x",[0]],["y",[0]]]}}},"view":{"type":"object","name":"CDSView","id":"p4124","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p4125"}}},"glyph":{"type":"object","name":"Line","id":"p4120","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"line_color":"#EA3829","line_width":2,"line_dash":[6]}},"nonselection_glyph":{"type":"object","name":"Line","id":"p4121","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"line_color":"#EA3829","line_alpha":0.1,"line_width":2,"line_dash":[6]}},"muted_glyph":{"type":"object","name":"Line","id":"p4122","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"line_color":"#EA3829","line_alpha":0.2,"line_width":2,"line_dash":[6]}}}}],"toolbar":{"type":"object","name":"Toolbar","id":"p4083","attributes":{"tools":[{"type":"object","name":"HoverTool","id":"p4097","attributes":{"renderers":"auto","tooltips":[["topic","@metadata_values"],["Correctness","@correctness{0.00}"]]}}]}},"toolbar_location":null,"left":[{"type":"object","name":"CategoricalAxis","id":"p4092","attributes":{"ticker":{"type":"object","name":"CategoricalTicker","id":"p4093"},"formatter":{"type":"object","name":"CategoricalTickFormatter","id":"p4094"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p4095"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"below":[{"type":"object","name":"LinearAxis","id":"p4087","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p4088","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p4089"},"axis_label":"Correctness (%)","axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p4090"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"center":[{"type":"object","name":"Grid","id":"p4091","attributes":{"axis":{"id":"p4087"},"grid_line_color":"#E0E0E0","grid_line_alpha":0.25}},{"type":"object","name":"Grid","id":"p4096","attributes":{"dimension":1,"axis":{"id":"p4092"},"grid_line_color":"#E0E0E0","grid_line_alpha":0.25}},{"type":"object","name":"Span","id":"p4116","attributes":{"location":68.0,"dimension":"height","line_color":"#EA3829","line_width":2,"line_dash":[6]}},{"type":"object","name":"Legend","id":"p4126","attributes":{"border_line_alpha":0,"background_fill_color":"#111516","background_fill_alpha":0.5,"label_text_color":"#E0E0E0","label_text_font":"Helvetica","label_text_font_size":"1.025em","label_standoff":8,"glyph_width":15,"spacing":8,"items":[{"type":"object","name":"LegendItem","id":"p4127","attributes":{"label":{"type":"value","value":"Correctness on the entire Testset"},"renderers":[{"id":"p4123"}]}}]}}],"background_fill_color":"#14191B","border_fill_color":"#15191C"}}]}}';
        const render_items = [{"docid":"f417c8e8-62cf-4bc7-811a-28f5bfc67656","roots":{"p4075":"e68007fa-2edd-4f2c-a589-2ac40f77cc31"},"root_ids":["p4075"]}];
        root.Bokeh.embed.embed_items(docs_json, render_items);
        }
        if (root.Bokeh !== undefined) {
          embed_document(root);
        } else {
          let attempts = 0;
          const timer = setInterval(function(root) {
            if (root.Bokeh !== undefined) {
              clearInterval(timer);
              embed_document(root);
            } else {
              attempts++;
              if (attempts > 100) {
                clearInterval(timer);
                console.log("Bokeh: ERROR: Unable to run BokehJS code because BokehJS library is missing");
              }
            }
          }, 10, root)
        }
      })(window);
    });
  };
  if (document.readyState != "loading") fn();
  else document.addEventListener("DOMContentLoaded", fn);
})();
    </script>

                <div id="e68007fa-2edd-4f2c-a589-2ac40f77cc31" data-root-id="p4075" style="display: contents;"></div>
            </div>
        </div>

        <div class="section-container">
            <div class="section-card">
                <div class="section-title">KNOWLEDGE BASE OVERVIEW</div>
                    <script type="text/javascript">
        (function() {
  const fn = function() {
    Bokeh.safely(function() {
      (function(root) {
        function embed_document(root) {
        const docs_json = '{"4589ef04-00b9-4d27-8c90-a9a84be3eb67":{"version":"3.4.3","title":"Bokeh Application","roots":[{"type":"object","name":"Tabs","id":"p4006","attributes":{"sizing_mode":"stretch_width","tabs":[{"type":"object","name":"TabPanel","id":"p3936","attributes":{"title":"Topic exploration","child":{"type":"object","name":"Figure","id":"p3889","attributes":{"sizing_mode":"stretch_width","x_range":{"type":"object","name":"Range1d","id":"p3898","attributes":{"start":14.89843554496765,"end":24.761622047424318}},"y_range":{"type":"object","name":"Range1d","id":"p3899","attributes":{"start":1.152787685394287,"end":6.696872234344482}},"x_scale":{"type":"object","name":"LinearScale","id":"p3900"},"y_scale":{"type":"object","name":"LinearScale","id":"p3901"},"title":{"type":"object","name":"Title","id":"p3896","attributes":{"text_color":"#E0E0E0","text_font":"Helvetica","text_font_size":"14pt"}},"outline_line_color":"#E0E0E0","outline_line_alpha":0.25,"renderers":[{"type":"object","name":"GlyphRenderer","id":"p3929","attributes":{"data_source":{"type":"object","name":"ColumnDataSource","id":"p3886","attributes":{"selected":{"type":"object","name":"Selection","id":"p3887","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p3888"},"data":{"type":"map","entries":[["x",{"type":"ndarray","array":{"type":"bytes","data":"duqJQbu+ikFxwohBgYeDQcqse0FanX5BwK6EQQ53h0Est4VBM+6AQUM6e0E5KHNBknuMQTTdkEGoBY5BSoKQQfRslEF9apBB0MmTQSiGmUGXqaZBp1qfQQNeokESJqJBa2apQY4apEFSRalBF2qXQVmGmEH/cZtBisueQVrFpEE="},"shape":[32],"dtype":"float32","order":"little"}],["y",{"type":"ndarray","array":{"type":"bytes","data":"dphtQJa1oUAHFoZAjTQ+QPUcDkC47zpAUuoEQLD8MUBbEphA2WuJQA4MbkDEdEtAbsMrQOoZgUCBLA1ARnxMQFpKLUADwJ5AQbu4QCFqtECJp15AInplQFYBRUCAnp5AvFd+QM7Qh0DaraJAj5SOQAU/ckDeTpdAqx24QAK7tUA="},"shape":[32],"dtype":"float32","order":"little"}],["topic",["Others","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Others","Others","Benzodiazepine Risks and Effects","Others","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs"]],["id",[0,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,26,27,28,29,30,31,32,33]],["content",["CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE -\\nchlordiazepoxide hydrochloride and clidinium bromide capsule \\n \\nAlembic Pharmaceuticals Inc.\\n----------\\nChlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP\\nfor oral use\\nWARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE,\\nMISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL\\nREACTIONS\\n \\nConcomitant use of benzodiazepines and opioids may result in\\nprofound sedation, respiratory depression, coma, and death. Reserve\\nconcomitan...","Each chlordiazepoxide hydrochloride and clidinium bromide capsule, USP contains the\\nactive ingredients 5 mg chlordiazepoxide hydrochloride, USP and 2.5 mg clidinium\\nbromide, USP. Each capsule also contains the inactive ingredients lactose monohydrate,\\ncorn starch, talc, titanium dioxide, FD&amp;C Green 3, D&amp;C Yellow 10 and gelatin. The empty\\nhard gelatin capsule shells are printed with edible black ink containing shellac, propylene\\nglycol,  black iron oxide and potassium hydroxide.\\nChlordiazepoxide ...","the maximum recommended human dose of 40 mg/day, based on body surface area)\\nexhibited major skeletal defects.\\nTwo series of reproduction experiments with clidinium bromide were carried out in rats,\\nemploying dosages of 2.5 and 10 mg/kg daily (1.2 and 4.9 times, respectively, the\\nmaximum recommended clinical dose of 20 mg/day, based on body surface area) in\\neach experiment. In the first experiment, clidinium bromide was administered for a 9-\\nweek interval prior to mating; no untoward effect on f...","Risks From Concomitant Use with Opioids\\nConcomitant use of benzodiazepines, including chlordiazepoxide hydrochloride and\\nclidinium bromide and opioids may result in profound sedation, respiratory depression,\\ncoma, and death. Because of these risks, reserve concomitant prescribing of these\\ndrugs -in patients for whom alternative treatment options are inadequate.\\nObservational studies have demonstrated that concomitant use of opioid analgesics and\\nbenzodiazepines increases the risk of drug-related...","those who have had longer durations of use.\\nAcute Withdrawal Reactions\\nThe continued use of benzodiazepines, including chlordiazepoxide hydrochloride and\\nclidinium bromide capsules, may lead to clinically significant physical dependence. Abrupt\\ndiscontinuation or rapid dosage reduction of chlordiazepoxide hydrochloride and\\nclidinium bromide capsules after continued use, or administration of flumazenil (a\\nbenzodiazepine antagonist) may precipitate acute withdrawal reactions, which can be\\nlife-thr...","as the MAO inhibitors and phenothiazines are to be used. The usual precautions in\\ntreating patients with impaired renal or hepatic function should be observed.\\nParadoxical reactions to chlordiazepoxide hydrochloride, e.g., excitement, stimulation\\nand acute rage, have been reported in psychiatric patients and should be watched for\\nduring chlordiazepoxide hydrochloride and clidinium bromide capsules therapy. The\\nusual precautions are indicated when chlordiazepoxide hydrochloride is used in the\\ntre...","Pregnancy\\n). Instruct patients to inform their healthcare provider if they are pregnant.\\nNursing\\nInstruct patients to notify their healthcare provider if they are breastfeeding or intend to\\nbreastfeed (see \\nPRECAUTIONS, Nursing Mothers\\n).\\nDrug Interactions\\nOpioids\\n \\nThe concomitant use of benzodiazepines, including chlordiazepoxide hydrochloride, a\\ncomponent of chlordiazepoxide hydrochloride and clidinium bromide capsules and\\nopioids increases the risk of respiratory depression because of action...","defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to\\n20%, respectively.\\nClinical Considerations\\nFetal/Neonatal Adverse Reactions\\nBenzodiazepines cross the placenta and may produce respiratory depression, hypotonia\\nand sedation in neonates. Monitor neonates exposed to chlordiazepoxide hydrochloride\\nand clidinium bromide capsules, which contains a benzodiazepine (chlordiazepoxide\\nhydrochloride), during pregnancy or labor for signs of sedation, respiratory depression,...","Reproduction studies in rats fed chlordiazepoxide hydrochloride, 10, 20 and 80 mg/kg\\ndaily (2.4, 4.8 and 19.4 times respectively, the maximum recommended clinical dose of\\n40 mg/day, based on body surface area), and bred through one or two matings showed\\nno adverse effects on lactation of the dams.\\nClidinium Bromide\\nThere are no data on the presence of clidinium in either human or animal milk, the\\neffects on the breastfed infant, or the effects on milk production. As with other\\nanticholinergic dr...","instances syncope has been reported.\\nOther adverse reactions reported during therapy with chlordiazepoxide hydrochloride\\ninclude isolated instances of skin eruptions, edema, minor menstrual irregularities,\\nnausea and constipation, extrapyramidal symptoms, as well as increased and decreased\\nlibido. Such side effects have been infrequent and are generally controlled with reduction\\nof dosage. Changes in EEG patterns (low-voltage fast activity) have been observed in\\npatients during and after chlordi...","Abuse and misuse of benzodiazepines often (but not always) involve the use of doses\\ngreater than the maximum recommended dosage and commonly involve concomitant\\nuse of other medications, alcohol, and/or illicit substances, which is associated with an\\nincreased frequency of serious adverse outcomes, including respiratory depression,\\noverdose, or death. Benzodiazepines are often sought by individuals who abuse drugs\\nand other substances, and by individuals with addictive disorders (see \\nWARNINGS\\n)...","seizures and suicidality.\\nProtracted Withdrawal Syndrome\\nProtracted withdrawal syndrome associated with benzodiazepines is characterized by\\nanxiety, cognitive impairment, depression, insomnia, formication, motor symptoms (e.g.,\\nweakness, tremor, muscle twitches), paresthesia, and tinnitus that persists beyond 4 to\\n6 weeks after initial benzodiazepine withdrawal. Protracted withdrawal symptoms may\\nlast weeks to more than 12 months. As a result, there may be difficulty in differentiating\\nwithdrawa...","overdosage. Anticholinergic drugs usually increase heart rate and blood pressure. In\\nmanaging benzodiazepine overdosage, employ general supportive measures, including\\nintravenous fluids, and airway management.\\nFlumazenil, a specific benzodiazepine receptor antagonist is indicated for the complete\\nor partial reversal of the sedative effects of benzodiazepines in the management of\\nbenzodiazepine overdosage. Use of flumazenil may increase the risk of seizures in\\nmixed overdosage with drugs that may...","on cap and \\u201c333\\u201d on body with black ink, filled with white to off white powder.\\nBottle of 100 capsules with child resistant closure, NDC 62332-744-31\\nBottle of 1000 capsules, NDC 62332-744-91\\nStore at 25\\u00b0C (77\\u00b0F); excursions permitted to 15\\u00b0 to 30\\u00b0C (59\\u00b0 to 86\\u00b0F) [see USP\\nControlled Room Temperature]. Protect from light.\\nKeep out of reach of children.\\nDispense in tight, light-resistant container as defined in USP/NF.\\nMedication Guide available at \\nhttps://www.alembicusa.com/medicationguide.aspx ...","bromide capsules, which can lead to overdose or death. \\n        o \\nSerious side effects including coma and death have happened in people\\nwho have abused or misused benzodiazepines, including chlordiazepoxide\\nhydrochloride and clidinium bromide capsules. \\nThese serious side effects may also\\ninclude delirium, paranoia, suicidal thoughts or actions, seizures, and difficulty breathing.\\nCall your healthcare provider or go to the nearest hospital emergency room\\nright away if you get any of these serio...","clidinium bromide capsules may harm others. Tell your healthcare provider if you have\\nabused or been dependent on alcohol, prescription medicines or street drugs. \\n\\u2022 It is not known if chlordiazepoxide hydrochloride and clidinium bromide capsule is safe\\nand effective in children. \\n \\nDo not take chlordiazepoxide hydrochloride and clidinium bromide capsules if\\nyou: \\n\\u2022 have glaucoma \\n\\u2022 have an enlarged prostate \\n\\u2022 have a blockage of your bladder that causes problems with urination \\n\\u2022 are allergic t...","hydrochloride and clidinium bromide capsules or suddenly stop taking chlordiazepoxide\\nhydrochloride and clidinium bromide capsules without talking with your healthcare\\nprovider. \\n\\u2022 If you take too much chlordiazepoxide hydrochloride and clidinium bromide capsules,\\ncall your healthcare provider or go to the nearest hospital emergency room right away. \\nWhat are the possible side effects of chlordiazepoxide hydrochloride and\\nclidinium bromide capsules? \\nChlordiazepoxide hydrochloride and clidinium ...","that is written for health professionals.\\nWhat are the ingredients in chlordiazepoxide hydrochloride and clidinium\\nbromide capsules? \\nActive ingredients:\\n chlordiazepoxide hydrochloride and clidinium bromide \\nInactive ingredients: \\nlactose monohydrate, corn starch, talc, titanium dioxide, FD&amp;C\\nGreen 3, D&amp;C Yellow 10 and gelatin. The empty hard gelatin capsule shells are printed\\nwith edible black ink containing shellac, propylene glycol,  iron oxide and black iron oxide\\nand potassium hydroxide. \\n...","CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE  \\nchlordiazepoxide hydrochloride and clidinium bromide capsule\\nProduct Information\\nProduct Type\\nHUMAN PRESCRIPTION DRUG\\nItem Code (Source)\\nNDC:62332-744\\nRoute of Administration\\nORAL\\nDEA Schedule\\nCIV    \\nActive Ingredient/Active Moiety\\nIngredient Name\\nBasis of Strength\\nStrength\\nCHLORDIAZEPOXIDE HYDROCHLORIDE\\n (UNII: MFM6K1XWDK)\\n(CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR)\\nCHLORDIAZEPOXIDE\\nHYDROCHLORIDE\\n5 mg\\nCLIDINIUM BROMIDE\\n (UNII: 91ZQW5JF1Z) \\n(CLIDI...","Alembic Pharmaceuticals Inc.\\nPOTASSIUM HYDROXIDE\\n (UNII: WZH3C48M4T)\\n \\nPROPYLENE GLYCOL\\n (UNII: 6DC9Q167V3)\\n \\nProduct Characteristics\\nColor\\nGREEN (Light green opaque cap) , GREEN (Light green opaque body)\\nScore\\nno score\\nShape\\nCAPSULE\\nSize\\n16mm\\nFlavor\\nImprint Code\\nA;333\\nContains\\n    \\nPackaging\\n#\\nItem Code\\nPackage Description\\nMarketing Start\\nDate\\nMarketing End\\nDate\\n1\\nNDC:62332-744-\\n31\\n100 \\nin 1 BOTTLE; Type 0: Not a Combination\\nProduct\\n10/04/2023\\n2\\nNDC:62332-744-\\n91\\n1000 \\nin 1 BOTTLE; Type 0: Not ...","IVERMECTIN- ivermectin lotion \\n \\nWalgreen Company\\n----------\\nIvermectin\\nDrug Facts\\nActive ingredient\\nIvermectin 0.5%\\nPurpose\\nLice treatment\\nUse\\ntreats head lice\\nWarnings\\nFor external use only. Use only on the scalp.\\nDo not use\\non children under 6 months of age\\nnear the eyes\\ninside the nose, ear, mouth, or vagina\\non lice in eyebrows or eyelashes. See a doctor if lice are present in these areas.\\nAsk a doctor before use if you\\nhave any skin conditions or sensitivities\\nare pregnant or plan to become...","If pregnant or breastfeeding,\\n ask a health professional before use.\\nKeep out of reach of children.\\nIf swallowed, get medical help or contact a Poison Control Center (1-800-222-1222)\\nright away.\\nDirections\\nImportant: Read warnings before use\\nchildren 6 months of age to under 12 years of age: an adult should\\nsupervise use\\nadults and children 6 months of age and over:\\nInspect\\nall household members should be checked by another person for lice and/or nits\\n(eggs)\\nuse a magnifying glass in bright ligh...","this is a single use product. Discard tube after use.\\ndo not use again on the same person and same lice infestation without talking to a\\nhealthcare provider first\\nif infestation continues, see a doctor for other treatments\\nmachine wash any bedding and clothing used by anyone having lice. Machine wash at\\nhigh temperatures (150\\u00b0F) and tumble in a hot dryer for 20 minutes.\\nafter finishing treatment with lice medicine, check everyone in your family for lice\\nafter one week. Consider treatment for tho...","1\\nTUBE\\nNET WT 4 OZ (117 g)","IVERMECTIN","ivermectin lotion\\nProduct Information\\nProduct Type\\nHUMAN OTC DRUG\\nItem Code (Source)\\nNDC:0363-4230\\nRoute of Administration\\nTOPICAL\\nActive Ingredient/Active Moiety\\nIngredient Name\\nBasis of Strength\\nStrength\\nIvermectin\\n (UNII: 8883YP2R6D) \\n(Ivermectin - UNII:8883YP2R6D)\\nIvermectin\\n5 mg  in 1 g\\nInactive Ingredients\\nIngredient Name\\nStrength\\nbutylated hydroxyanisole\\n (UNII: REK4960K2U)\\n \\ncastor oil\\n (UNII: D5340Y2I9G)\\n \\ncetyl alcohol\\n (UNII: 936JST6JCN)\\n \\nANHYDROUS CITRIC ACID\\n (UNII: XF417D3PSL)\\n \\nc...","Walgreen Company\\nMarketing Information\\nMarketing\\nCategory\\nApplication Number or Monograph\\nCitation\\nMarketing Start\\nDate\\nMarketing End\\nDate\\nANDA\\nANDA210720\\n05/06/2020\\nLabeler - \\nWalgreen Company \\n(008965063)\\n \\nRevised: 1/2022","NYQUIL SEVERE COLD AND FLU- acetaminophen, dextromethorphan hydrobromide,\\ndoxylamine succinate, phenylephrine hydrochloride tablet, coated \\n \\nSavings Distributors LLC\\nDisclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they\\ncomply with applicable regulations and policies. FDA has not evaluated whether this product complies.\\n----------\\nNyQuil Severe Cold &amp; Flu\\nDrug Facts\\nActive ingredients (in each caplet)\\nAcetaminophen 325 mg\\nDextromethorphan HBr 10 m...","Sore throat warning:\\n If sore throat is severe, persists for more than 2 days, is accompanied or\\nfollowed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.\\nDo not use\\n\\u2022 with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure\\nwhether a drug contains acetaminophen, ask a doctor or pharmacist.\\n\\u2022 if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for\\ndepression, psychiatric or emotional conditions...","children under 4 yrs \\ndo not use\\nOther Information\\n\\u2022 do not exceed 25\\u00baC\\nInactive ingredients\\ncrospovidone, D&amp;C Yellow No.10 Aluminum Lake, \\nFD&amp;C Blue No.1 Aluminum Lake, FD&amp;C Blue\\nNo.2 Aluminum Lake,FD&amp;C Yellow No.6 Aluminum Lake, flavor, magnesium stearate, microcrystalline\\ncellulose, polyethylene glycol, polyvinyl alcohol, povidone, pregelatinized starch, silicon dioxide,\\nstearic acid, talc, titanium dioxide\\nQuestions?\\n1-800-362-1683\\nPackage Label\\nNYQUIL SEVERE COLD AND FLU","acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride tablet, coated\\nProduct Information\\nProduct Type\\nHUMAN OTC DRUG\\nItem Code (Source)\\nNDC:73097-009(NDC:37000-813)\\nRoute of Administration\\nORAL\\nActive Ingredient/Active Moiety\\nIngredient Name\\nBasis of Strength\\nStrength\\nACETAMINOPHEN\\n (UNII: 362O9ITL9D) \\n(ACETAMINOPHEN - UNII:362O9ITL9D)\\nACETAMINOPHEN\\n325 mg\\nDEXTROMETHORPHAN HYDROBROMIDE\\n (UNII: 9D2RTI9KYH)\\n(DEXTROMETHORPHAN - UNII:7355X3ROTS)\\nDEXTROMETHOR...","Savings Distributors LLC\\n3\\nNDC:73097-009-20\\n40 \\nin 1 CARTON\\n07/08/2019\\n3\\n2 \\nin 1 POUCH; Type 0: Not a Combination Product\\nMarketing Information\\nMarketing Category\\nApplication Number or Monograph Citation\\nMarketing Start Date\\nMarketing End Date\\nOTC monograph final\\npart341\\n07/08/2019\\nLabeler - \\nSavings Distributors LLC \\n(010527359)\\n \\nRevised: 7/2019"]],["color",{"type":"ndarray","array":["#999","#1f77b4","#1f77b4","#1f77b4","#1f77b4","#1f77b4","#1f77b4","#1f77b4","#1f77b4","#1f77b4","#1f77b4","#1f77b4","#1f77b4","#999","#999","#1f77b4","#999","#aec7e8","#aec7e8","#aec7e8","#aec7e8","#aec7e8","#aec7e8","#aec7e8","#aec7e8","#aec7e8","#aec7e8","#aec7e8","#aec7e8","#aec7e8","#aec7e8","#aec7e8"],"shape":[32],"dtype":"object","order":"little"}]]}}},"view":{"type":"object","name":"CDSView","id":"p3930","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p3931"}}},"glyph":{"type":"object","name":"Scatter","id":"p3926","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.7},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.7}}},"nonselection_glyph":{"type":"object","name":"Scatter","id":"p3927","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_alpha":{"type":"value","value":0.1},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.1},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"Scatter","id":"p3928","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_alpha":{"type":"value","value":0.2},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.2},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.2}}}}}],"toolbar":{"type":"object","name":"Toolbar","id":"p3897","attributes":{"logo":"grey","tools":[{"type":"object","name":"HoverTool","id":"p3912","attributes":{"renderers":"auto","tooltips":"\\n    &lt;div style=\\"width:400px;\\"&gt;\\n    &lt;b&gt;Document id:&lt;/b&gt; @id &lt;br&gt;\\n    &lt;b&gt;Topic:&lt;/b&gt; @topic &lt;br&gt;\\n    &lt;b&gt;Document Content:&lt;/b&gt; @content\\n    &lt;/div&gt;\\n    "}},{"type":"object","name":"PanTool","id":"p3913"},{"type":"object","name":"WheelZoomTool","id":"p3914","attributes":{"renderers":"auto"}},{"type":"object","name":"BoxZoomTool","id":"p3915","attributes":{"overlay":{"type":"object","name":"BoxAnnotation","id":"p3916","attributes":{"syncable":false,"level":"overlay","visible":false,"left":{"type":"number","value":"nan"},"right":{"type":"number","value":"nan"},"top":{"type":"number","value":"nan"},"bottom":{"type":"number","value":"nan"},"left_units":"canvas","right_units":"canvas","top_units":"canvas","bottom_units":"canvas","line_color":"black","line_alpha":1.0,"line_width":2,"line_dash":[4,4],"fill_color":"lightgrey","fill_alpha":0.5}}}},{"type":"object","name":"ResetTool","id":"p3921"},{"type":"object","name":"SaveTool","id":"p3922"}]}},"left":[{"type":"object","name":"LinearAxis","id":"p3907","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p3908","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p3909"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p3910"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"below":[{"type":"object","name":"LinearAxis","id":"p3902","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p3903","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p3904"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p3905"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"center":[{"type":"object","name":"Grid","id":"p3906","attributes":{"axis":{"id":"p3902"},"grid_line_color":"white","grid_line_alpha":0.25}},{"type":"object","name":"Grid","id":"p3911","attributes":{"dimension":1,"axis":{"id":"p3907"},"grid_line_color":"white","grid_line_alpha":0.25}},{"type":"object","name":"Legend","id":"p3932","attributes":{"title":"Knowledge Base Tospics","title_text_color":"#B1B1B1","title_text_font_style":"bold","border_line_alpha":0,"background_fill_color":"#111516","background_fill_alpha":0.5,"label_text_color":"#E0E0E0","label_text_font":"Helvetica","label_text_font_size":"1.025em","label_standoff":8,"glyph_width":15,"spacing":8,"items":[{"type":"object","name":"LegendItem","id":"p3933","attributes":{"label":{"type":"value","value":"Benzodiazepine Risks and Effects"},"renderers":[{"id":"p3929"}],"index":1}},{"type":"object","name":"LegendItem","id":"p3934","attributes":{"label":{"type":"value","value":"Others"},"renderers":[{"id":"p3929"}],"index":0}},{"type":"object","name":"LegendItem","id":"p3935","attributes":{"label":{"type":"value","value":"Over-the-Counter and Prescription Drugs"},"renderers":[{"id":"p3929"}],"index":17}}]}}],"background_fill_color":"#14191B","border_fill_color":"#15191C"}}}},{"type":"object","name":"TabPanel","id":"p4005","attributes":{"title":"Failures","child":{"type":"object","name":"Figure","id":"p3941","attributes":{"sizing_mode":"stretch_width","x_range":{"type":"object","name":"Range1d","id":"p3950","attributes":{"start":14.89843554496765,"end":24.761622047424318}},"y_range":{"type":"object","name":"Range1d","id":"p3951","attributes":{"start":1.152787685394287,"end":6.696872234344482}},"x_scale":{"type":"object","name":"LinearScale","id":"p3952"},"y_scale":{"type":"object","name":"LinearScale","id":"p3953"},"title":{"type":"object","name":"Title","id":"p3948","attributes":{"text_color":"#E0E0E0","text_font":"Helvetica","text_font_size":"14pt"}},"outline_line_color":"#E0E0E0","outline_line_alpha":0.25,"renderers":[{"type":"object","name":"GlyphRenderer","id":"p3980","attributes":{"data_source":{"type":"object","name":"ColumnDataSource","id":"p3937","attributes":{"selected":{"type":"object","name":"Selection","id":"p3938","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p3939"},"data":{"type":"map","entries":[["x",{"type":"ndarray","array":{"type":"bytes","data":"NN2QQVJFqUEst4VB/3GbQdDJk0EOd4dBA16iQYGHg0GoBY5BisueQZJ7jEGnWp9BSoKQQZeppkH0bJRBKIaZQXbqiUEXapdBWsWkQY4apEHAroRBccKIQcqse0G7vopBWp1+QQ=="},"shape":[25],"dtype":"float32","order":"little"}],["y",{"type":"ndarray","array":{"type":"bytes","data":"6hmBQNqtokBbEphA3k6XQEG7uECw/DFAVgFFQI00PkCBLA1Aqx24QG7DK0AiemVARnxMQImnXkBaSi1AIWq0QHaYbUCPlI5AAru1QM7Qh0BS6gRABxaGQPUcDkCWtaFAuO86QA=="},"shape":[25],"dtype":"float32","order":"little"}],["topic",["Others","Over-the-Counter and Prescription Drugs","Benzodiazepine Risks and Effects","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Benzodiazepine Risks and Effects","Over-the-Counter and Prescription Drugs","Benzodiazepine Risks and Effects","Others","Over-the-Counter and Prescription Drugs","Benzodiazepine Risks and Effects","Over-the-Counter and Prescription Drugs","Benzodiazepine Risks and Effects","Over-the-Counter and Prescription Drugs","Others","Over-the-Counter and Prescription Drugs","Others","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Over-the-Counter and Prescription Drugs","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects","Benzodiazepine Risks and Effects"]],["correctness",[true,true,true,true,false,false,true,true,false,false,true,true,true,true,true,false,true,true,false,false,true,true,true,true,false]],["questions",["Considering the potential risks associated with central nervous system depressants, what are the specific dangers of combining chlordiazepoxide hydrochloride and clidinium bromide capsules with either opioids or alcohol, and under what circumstances should one seek emergency assistance?","Considering the application number ANDA210720, could you specify the exact date on which the marketing efforts for this product commenced, and ensure that your response is based solely on the information provided by Walgreen Company?","Considering the lack of data on clidinium presence in milk and potential anticholinergic effects, what adverse effects should be monitored in breastfed infants when the mother is taking chlordiazepoxide hydrochloride and clidinium bromide?","Considering the recommended storage conditions, what is the maximum temperature that should not be exceeded when storing Nyquil Severe Cold and Flu, especially if it is stored in a location prone to temperature fluctuations?","In the prescription medication chlordiazepoxide hydrochloride and clidinium bromide capsule, what are the active ingredients along with their respective strengths, and how do these strengths compare to the inactive ingredients listed?","Considering the clinical considerations and available data, what are the potential adverse effects or risks that neonates might face if exposed to chlordiazepoxide hydrochloride and clidinium bromide capsules during pregnancy, and how should these neonates be monitored and managed?","If the lice infestation persists despite using the product as directed, including following all post-treatment steps like washing bedding and clothing at high temperatures, what is the recommended course of action before considering another application?","Considering the potential for profound sedation and respiratory depression, what are the specific dangers of using chlordiazepoxide hydrochloride and clidinium bromide together with opioids, and how should these risks be managed if alternative treatments are insufficient?","Under what circumstances might misuse or abuse of chlordiazepoxide hydrochloride and clidinium bromide capsules result in severe side effects, and what are these potential effects?","Could you detail the active ingredients along with their respective strengths in the coated tablet product, ensuring to include the exact milligram amounts for each component as specified in the product information?","Considering the increased sensitivity of elderly patients to medications, what is the advised starting dosage for chlordiazepoxide hydrochloride and clidinium bromide capsules, and how should the dosage be adjusted over time to avoid adverse effects such as ataxia or oversedation?","In the event that the product is accidentally ingested, what immediate actions should be taken, considering that the product is intended for treating lice and nits?","Under what specific health conditions or circumstances should one avoid taking chlordiazepoxide hydrochloride and clidinium bromide capsules, especially considering any potential allergic reactions or pre-existing medical issues?","Under what specific conditions and for which groups of individuals should the use of Ivermectin lotion be avoided or approached with caution, considering potential risks and warnings?","In the event of an overdose of chlordiazepoxide hydrochloride and clidinium bromide capsules, what immediate actions should you take, considering that you cannot drive or operate machinery due to the medication&#x27;s effects?","Under the condition that the capsules are light green with no score and measure 16mm, what is the specific imprint code found on the capsules produced by Alembic Pharmaceuticals Inc.?","Considering the potential for profound sedation and respiratory depression, what are the inherent dangers of using chlordiazepoxide hydrochloride and clidinium bromide capsules simultaneously with opioids, especially if alternative treatments are insufficient?","Could you enumerate the active ingredients in NyQuil Severe Cold &amp; Flu caplets, including their specific purposes, while also considering any warnings or restrictions related to their usage?","Under what specific conditions or regulatory category did Savings Distributors LLC initiate the marketing of their product, and what is the exact start date of this marketing phase?","In the context of the ivermectin lotion, could you identify the active ingredient and specify its concentration, considering the lotion is applied topically and is classified as a human OTC drug?","If a patient is either pregnant or breastfeeding while taking chlordiazepoxide hydrochloride and clidinium bromide capsules, what specific actions should they undertake, considering the potential risks and the lack of clear data on birth defects?","Under what specific medical conditions or patient sensitivities should one avoid taking chlordiazepoxide hydrochloride and clidinium bromide capsules, considering potential interactions with existing health issues?","Considering the documented effects on neonates, what are the specific risks and potential complications associated with the use of chlordiazepoxide hydrochloride and clidinium bromide capsules during pregnancy, especially in the later stages?","In the formulation of each chlordiazepoxide hydrochloride and clidinium bromide capsule, can you specify the active ingredients and their respective quantities, while also considering any additional substances present in the capsule?","What critical information must be conveyed to patients regarding the potential risks and necessary precautions when using chlordiazepoxide hydrochloride and clidinium bromide capsules, especially concerning abuse, withdrawal, and interactions with opioids or other CNS depressants?"]],["agent_answer",["The specific dangers of combining chlordiazepoxide hydrochloride and clidinium bromide capsules with opioids or alcohol include severe drowsiness, breathing problems (respiratory depression), coma, and death. Emergency assistance should be sought immediately if shallow or slowed breathing, breathing stops (which may lead to the heart stopping), or excessive sleepiness (sedation) occur.","Based solely on the information provided by Walgreen Company, the marketing efforts for the product with application number ANDA210720 commenced on 05/06/2020.","When the mother is taking chlordiazepoxide hydrochloride and clidinium bromide, breastfed infants should be monitored for sedation, poor feeding, and poor weight gain.","The maximum temperature that should not be exceeded when storing Nyquil Severe Cold and Flu is 25\\u00baC.","The active ingredients in the prescription medication chlordiazepoxide hydrochloride and clidinium bromide capsule are 5 mg of chlordiazepoxide hydrochloride, USP and 2.5 mg of clidinium bromide, USP. These strengths are higher compared to the inactive ingredients such as lactose monohydrate, corn starch, talc, titanium dioxide, FD&amp;C Green 3, D&amp;C Yellow 10, and gelatin.","Neonates born to mothers using chlordiazepoxide hydrochloride and clidinium bromide capsules during the later stages of pregnancy may experience symptoms of sedation and/or neonatal withdrawal. These neonates should be monitored for sedation, poor feeding, and poor weight gain. Management of these neonates should involve close monitoring of their symptoms and potentially providing appropriate medical intervention if needed.","Before considering another application, the recommended course of action if the lice infestation persists despite following all post-treatment steps is to see a doctor for other treatments.","The specific dangers of using chlordiazepoxide hydrochloride and clidinium bromide together with opioids include profound sedation, respiratory depression, coma, and even death. These risks should be managed by reserving concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate. If co-prescribing is necessary, it is recommended to prescribe the lowest effective dosages and minimum durations of concomitant use, closely monitor patients for signs and symptoms of respiratory depression and sedation, and advise both patients and caregivers about the risks involved.","Misuse or abuse of chlordiazepoxide hydrochloride and clidinium bromide capsules can result in severe side effects such as causing drowsiness, dizziness, slow thinking, and impairment of motor skills. This can lead to dangerous activities such as driving, operating heavy machinery, or other risky behaviors. Mixing with alcohol or other drugs that cause drowsiness can exacerbate these effects.","Based on the information provided, the active ingredients in the coated tablet product \\"Active FE\\u2122\\" are as follows:\\n\\n- .BETA.-CAROTENE: 2100 [iU]\\n- ASCORBIC ACID: Not specified in milligram amounts\\n\\nUnfortunately, the exact milligram amount for Ascorbic Acid is not provided in the information given. So, only the strength of .BETA.-CAROTENE is specified as 2100 [iU].","The advised starting dosage for chlordiazepoxide hydrochloride and clidinium bromide capsules for elderly patients is no more than 2 capsules per day. The dosage should be increased gradually as needed and tolerated to avoid adverse effects such as ataxia or oversedation.","If the product is accidentally ingested, it is important to get medical help or contact a Poison Control Center (1-800-222-1222) right away.","One should avoid taking chlordiazepoxide hydrochloride and clidinium bromide capsules if they have glaucoma, an enlarged prostate, a blockage of the bladder causing urination problems, or if they are allergic to chlordiazepoxide hydrochloride or clidinium bromide.","The use of Ivermectin lotion should be avoided or approached with caution under the following conditions and for the following groups of individuals:\\n- Do not use on children under 6 months of age\\n- Do not use near the eyes, inside the nose, ear, mouth, or vagina\\n- Do not use on lice in eyebrows or eyelashes\\n- People with any skin conditions or sensitivities\\n- Pregnant individuals or those planning to become pregnant\\n- Individuals who are currently breastfeeding or planning to breastfeed","If there is an overdose of chlordiazepoxide hydrochloride and clidinium bromide capsules and you cannot drive or operate machinery due to the medication&#x27;s effects, the immediate action to take would be to call your healthcare provider or go to the nearest hospital emergency room right away.","Based on the information provided in the context, the specific imprint code found on the capsules produced by Alembic Pharmaceuticals Inc. is not mentioned. Therefore, I do not know the specific imprint code for the capsules in question.","The inherent dangers of using chlordiazepoxide hydrochloride and clidinium bromide capsules simultaneously with opioids include profound sedation, respiratory depression, coma, and potentially death. It is crucial to reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate due to the increased risk of drug-related mortality compared to using opioids alone.","The active ingredients in NyQuil Severe Cold &amp; Flu caplets are:\\n\\n- Acetaminophen (325 mg) - Pain reliever/fever reducer\\n- Dextromethorphan HBr (10 mg) - Cough suppressant\\n- Doxylamine succinate (6.25 mg) - Antihistamine\\n- Phenylephrine HCL (5 mg) - Nasal decongestant\\n\\nOne of the warnings related to the usage of NyQuil Severe Cold &amp; Flu caplets is a liver warning. Additionally, it is mentioned that children under 4 years old should not use this product.","Savings Distributors LLC initiated the marketing of their product under the OTC monograph final part 341 regulatory category, and the exact start date of this marketing phase was 07/08/2019.","The active ingredient in the ivermectin lotion is Ivermectin, and its concentration is 0.5%.","If a patient is either pregnant or breastfeeding while taking chlordiazepoxide hydrochloride and clidinium bromide capsules, they should immediately inform their healthcare provider. This is important because there are potential risks associated with harm to the unborn baby during pregnancy, such as symptoms of sedation and withdrawal in the baby. Additionally, during breastfeeding, the medication may pass through breast milk and cause sedation, poor feeding, or weight gain in the baby. It is advised to speak with a healthcare provider about the best way to feed the baby and to monitor any potential decrease in breast milk production. Given the lack of clear data on birth defects from the use of these capsules, healthcare provider guidance is crucial in these situations.","One should avoid taking chlordiazepoxide hydrochloride and clidinium bromide capsules if they have glaucoma, an enlarged prostate, a blockage of the bladder causing problems with urination, or if they are allergic to chlordiazepoxide hydrochloride or clidinium bromide.","The specific risks and potential complications associated with the use of chlordiazepoxide hydrochloride and clidinium bromide capsules during pregnancy, especially in the later stages, include symptoms of sedation and/or neonatal withdrawal in neonates born to mothers using benzodiazepines. Additionally, there may be a risk of neonatal sedation and withdrawal syndrome.","The active ingredients in each chlordiazepoxide hydrochloride and clidinium bromide capsule are 5 mg of chlordiazepoxide hydrochloride, USP and 2.5 mg of clidinium bromide, USP. In addition to these active ingredients, each capsule also contains lactose monohydrate, corn starch, talc, titanium dioxide, FD&amp;C Green 3, D&amp;C Yellow 10, and gelatin. The empty hard gelatin capsule shells are printed with edible black ink containing shellac, propylene glycol, black iron oxide, and potassium hydroxide.","Patients must be informed about the risks of abuse, misuse, and addiction associated with chlordiazepoxide hydrochloride and clidinium bromide capsules, especially when used in combination with other medications, alcohol, or illicit substances. They should also be educated about the signs and symptoms of benzodiazepine abuse, misuse, and addiction, instructed to seek medical help if these signs develop, and advised on the proper disposal of unused medication. Furthermore, patients need to be aware that abrupt discontinuation or rapid dosage reduction of the capsules may lead to acute withdrawal reactions and potentially life-threatening consequences. Finally, patients should be informed about the potentially fatal additive effects that can occur when using chlordiazepoxide hydrochloride and clidinium bromide capsules with opioids or other CNS depressants, including alcohol, and should only use these medications together under the supervision of a healthcare provider."]],["reference_answer",["Taking chlordiazepoxide hydrochloride and clidinium bromide capsules with opioid medicines, alcohol, or other central nervous system (CNS) depressants can cause severe drowsiness, breathing problems (respiratory depression), coma, and death.","The marketing start date is 05/06/2020.","Infants exposed to chlordiazepoxide hydrochloride and clidinium bromide through breast milk should be monitored for sedation, poor feeding and poor weight gain.","Do not exceed 25\\u00baC.","The active ingredients are chlordiazepoxide hydrochloride with a strength of 5 mg and clidinium bromide with a strength of 2.5 mg.","Neonates exposed to chlordiazepoxide hydrochloride and clidinium bromide capsules during pregnancy may experience respiratory depression, hypotonia, sedation, and feeding problems. They should be monitored for signs of sedation, respiratory depression, hypotonia, and feeding problems, as well as for signs of withdrawal.","If infestation continues, see a doctor for other treatments.","Concomitant use of benzodiazepines, including chlordiazepoxide hydrochloride and clidinium bromide and opioids may result in profound sedation, respiratory depression, coma, and death.","Serious side effects of abusing or misusing chlordiazepoxide hydrochloride and clidinium bromide capsules include coma, death, delirium, paranoia, suicidal thoughts or actions, seizures, and difficulty breathing.","The active ingredients and their strengths are: Acetaminophen 325 mg, Dextromethorphan Hydrobromide 10 mg, Doxylamine Succinate 6.25 mg, and Phenylephrine Hydrochloride 5 mg.","The initial dose should not exceed 2 chlordiazepoxide hydrochloride and clidinium bromide capsules per day, to be increased gradually as needed and tolerated.","If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.","Do not take chlordiazepoxide hydrochloride and clidinium bromide capsules if you have glaucoma, have an enlarged prostate, have a blockage of your bladder that causes problems with urination, or are allergic to chlordiazepoxide hydrochloride or clidinium bromide.","For external use only. Use only on the scalp. Do not use on children under 6 months of age, near the eyes, inside the nose, ear, mouth, or vagina, or on lice in eyebrows or eyelashes. See a doctor if lice are present in these areas. Ask a doctor before use if you have any skin conditions or sensitivities, are pregnant or plan to become pregnant, or are currently or planning to breastfeed. Avoid getting product on your breast to help prevent contact by your baby.","If you take too much chlordiazepoxide hydrochloride and clidinium bromide capsules, call your healthcare provider or go to the nearest hospital emergency room right away.","The imprint code on the capsules is A;333.","Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death.","The active ingredients in NyQuil Severe Cold &amp; Flu caplets are Acetaminophen 325 mg (Pain reliever/fever reducer), Dextromethorphan HBr 10 mg (Cough suppressant), Doxylamine succinate 6.25 mg (Antihistamine), and Phenylephrine HCL 5 mg (Nasal decongestant).","The marketing start date is 07/08/2019.","The active ingredient in the ivermectin lotion is Ivermectin, with a strength of 5 mg in 1 g.","Patients should inform their healthcare provider if they are pregnant or intend to breastfeed while taking chlordiazepoxide hydrochloride and clidinium bromide capsules.","Chlordiazepoxide hydrochloride and clidinium bromide capsules are contraindicated in the presence of glaucoma, in patients with prostatic hypertrophy and benign bladder neck obstruction, and in patients with known hypersensitivity to chlordiazepoxide hydrochloride and/or clidinium bromide.","Use of benzodiazepines late in pregnancy can result in sedation (respiratory depression, lethargy, hypotonia) and/or withdrawal symptoms (hyperreflexia, irritability, restlessness, tremors, inconsolable crying, and feeding difficulties) in the neonate. Neonates exposed to chlordiazepoxide hydrochloride and clidinium bromide capsules during pregnancy should be monitored for signs of sedation and withdrawal.","Each capsule contains the active ingredients 5 mg chlordiazepoxide hydrochloride, USP and 2.5 mg clidinium bromide, USP.","Patients should be informed that the use of chlordiazepoxide hydrochloride and clidinium bromide capsules exposes them to risks of abuse, misuse, and addiction, which can lead to overdose and death, especially when used with other medications, alcohol, and/or illicit substances. They should also be informed about the signs and symptoms of benzodiazepine abuse, misuse, and addiction, and seek medical help if they develop these signs and/or symptoms. Additionally, they should be informed about the risk of withdrawal reactions, the potential for physical dependence, and the need for a slow taper when discontinuing the medication. Patients and caregivers should be warned about the potentially fatal additive effects if used with opioids or other CNS depressants. Pregnant females should be advised that use late in pregnancy can result in sedation and/or withdrawal symptoms in newborns."]],["id",[13,28,8,31,18,7,22,3,14,32,12,21,15,20,16,19,0,29,33,27,6,2,4,1,5]],["content",["on cap and \\u201c333\\u201d on body with black ink, filled with white to off white powder.\\nBottle of 100 capsules with child resistant closure, NDC 62332-744-31\\nBottle of 1000 capsules, NDC 62332-744-91\\nStore at 25\\u00b0C (77\\u00b0F); excursions permitted to 15\\u00b0 to 30\\u00b0C (59\\u00b0 to 86\\u00b0F) [see USP\\nControlled Room Temperature]. Protect from light.\\nKeep out of reach of children.\\nDispense in tight, light-resistant container as defined in USP/NF.\\nMedication Guide available at \\nhttps://www.alembicusa.com/medicationguide.aspx ...","Walgreen Company\\nMarketing Information\\nMarketing\\nCategory\\nApplication Number or Monograph\\nCitation\\nMarketing Start\\nDate\\nMarketing End\\nDate\\nANDA\\nANDA210720\\n05/06/2020\\nLabeler - \\nWalgreen Company \\n(008965063)\\n \\nRevised: 1/2022","Reproduction studies in rats fed chlordiazepoxide hydrochloride, 10, 20 and 80 mg/kg\\ndaily (2.4, 4.8 and 19.4 times respectively, the maximum recommended clinical dose of\\n40 mg/day, based on body surface area), and bred through one or two matings showed\\nno adverse effects on lactation of the dams.\\nClidinium Bromide\\nThere are no data on the presence of clidinium in either human or animal milk, the\\neffects on the breastfed infant, or the effects on milk production. As with other\\nanticholinergic dr...","children under 4 yrs \\ndo not use\\nOther Information\\n\\u2022 do not exceed 25\\u00baC\\nInactive ingredients\\ncrospovidone, D&amp;C Yellow No.10 Aluminum Lake, \\nFD&amp;C Blue No.1 Aluminum Lake, FD&amp;C Blue\\nNo.2 Aluminum Lake,FD&amp;C Yellow No.6 Aluminum Lake, flavor, magnesium stearate, microcrystalline\\ncellulose, polyethylene glycol, polyvinyl alcohol, povidone, pregelatinized starch, silicon dioxide,\\nstearic acid, talc, titanium dioxide\\nQuestions?\\n1-800-362-1683\\nPackage Label\\nNYQUIL SEVERE COLD AND FLU","CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE  \\nchlordiazepoxide hydrochloride and clidinium bromide capsule\\nProduct Information\\nProduct Type\\nHUMAN PRESCRIPTION DRUG\\nItem Code (Source)\\nNDC:62332-744\\nRoute of Administration\\nORAL\\nDEA Schedule\\nCIV    \\nActive Ingredient/Active Moiety\\nIngredient Name\\nBasis of Strength\\nStrength\\nCHLORDIAZEPOXIDE HYDROCHLORIDE\\n (UNII: MFM6K1XWDK)\\n(CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR)\\nCHLORDIAZEPOXIDE\\nHYDROCHLORIDE\\n5 mg\\nCLIDINIUM BROMIDE\\n (UNII: 91ZQW5JF1Z) \\n(CLIDI...","defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to\\n20%, respectively.\\nClinical Considerations\\nFetal/Neonatal Adverse Reactions\\nBenzodiazepines cross the placenta and may produce respiratory depression, hypotonia\\nand sedation in neonates. Monitor neonates exposed to chlordiazepoxide hydrochloride\\nand clidinium bromide capsules, which contains a benzodiazepine (chlordiazepoxide\\nhydrochloride), during pregnancy or labor for signs of sedation, respiratory depression,...","this is a single use product. Discard tube after use.\\ndo not use again on the same person and same lice infestation without talking to a\\nhealthcare provider first\\nif infestation continues, see a doctor for other treatments\\nmachine wash any bedding and clothing used by anyone having lice. Machine wash at\\nhigh temperatures (150\\u00b0F) and tumble in a hot dryer for 20 minutes.\\nafter finishing treatment with lice medicine, check everyone in your family for lice\\nafter one week. Consider treatment for tho...","Risks From Concomitant Use with Opioids\\nConcomitant use of benzodiazepines, including chlordiazepoxide hydrochloride and\\nclidinium bromide and opioids may result in profound sedation, respiratory depression,\\ncoma, and death. Because of these risks, reserve concomitant prescribing of these\\ndrugs -in patients for whom alternative treatment options are inadequate.\\nObservational studies have demonstrated that concomitant use of opioid analgesics and\\nbenzodiazepines increases the risk of drug-related...","bromide capsules, which can lead to overdose or death. \\n        o \\nSerious side effects including coma and death have happened in people\\nwho have abused or misused benzodiazepines, including chlordiazepoxide\\nhydrochloride and clidinium bromide capsules. \\nThese serious side effects may also\\ninclude delirium, paranoia, suicidal thoughts or actions, seizures, and difficulty breathing.\\nCall your healthcare provider or go to the nearest hospital emergency room\\nright away if you get any of these serio...","acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride tablet, coated\\nProduct Information\\nProduct Type\\nHUMAN OTC DRUG\\nItem Code (Source)\\nNDC:73097-009(NDC:37000-813)\\nRoute of Administration\\nORAL\\nActive Ingredient/Active Moiety\\nIngredient Name\\nBasis of Strength\\nStrength\\nACETAMINOPHEN\\n (UNII: 362O9ITL9D) \\n(ACETAMINOPHEN - UNII:362O9ITL9D)\\nACETAMINOPHEN\\n325 mg\\nDEXTROMETHORPHAN HYDROBROMIDE\\n (UNII: 9D2RTI9KYH)\\n(DEXTROMETHORPHAN - UNII:7355X3ROTS)\\nDEXTROMETHOR...","overdosage. Anticholinergic drugs usually increase heart rate and blood pressure. In\\nmanaging benzodiazepine overdosage, employ general supportive measures, including\\nintravenous fluids, and airway management.\\nFlumazenil, a specific benzodiazepine receptor antagonist is indicated for the complete\\nor partial reversal of the sedative effects of benzodiazepines in the management of\\nbenzodiazepine overdosage. Use of flumazenil may increase the risk of seizures in\\nmixed overdosage with drugs that may...","If pregnant or breastfeeding,\\n ask a health professional before use.\\nKeep out of reach of children.\\nIf swallowed, get medical help or contact a Poison Control Center (1-800-222-1222)\\nright away.\\nDirections\\nImportant: Read warnings before use\\nchildren 6 months of age to under 12 years of age: an adult should\\nsupervise use\\nadults and children 6 months of age and over:\\nInspect\\nall household members should be checked by another person for lice and/or nits\\n(eggs)\\nuse a magnifying glass in bright ligh...","clidinium bromide capsules may harm others. Tell your healthcare provider if you have\\nabused or been dependent on alcohol, prescription medicines or street drugs. \\n\\u2022 It is not known if chlordiazepoxide hydrochloride and clidinium bromide capsule is safe\\nand effective in children. \\n \\nDo not take chlordiazepoxide hydrochloride and clidinium bromide capsules if\\nyou: \\n\\u2022 have glaucoma \\n\\u2022 have an enlarged prostate \\n\\u2022 have a blockage of your bladder that causes problems with urination \\n\\u2022 are allergic t...","IVERMECTIN- ivermectin lotion \\n \\nWalgreen Company\\n----------\\nIvermectin\\nDrug Facts\\nActive ingredient\\nIvermectin 0.5%\\nPurpose\\nLice treatment\\nUse\\ntreats head lice\\nWarnings\\nFor external use only. Use only on the scalp.\\nDo not use\\non children under 6 months of age\\nnear the eyes\\ninside the nose, ear, mouth, or vagina\\non lice in eyebrows or eyelashes. See a doctor if lice are present in these areas.\\nAsk a doctor before use if you\\nhave any skin conditions or sensitivities\\nare pregnant or plan to become...","hydrochloride and clidinium bromide capsules or suddenly stop taking chlordiazepoxide\\nhydrochloride and clidinium bromide capsules without talking with your healthcare\\nprovider. \\n\\u2022 If you take too much chlordiazepoxide hydrochloride and clidinium bromide capsules,\\ncall your healthcare provider or go to the nearest hospital emergency room right away. \\nWhat are the possible side effects of chlordiazepoxide hydrochloride and\\nclidinium bromide capsules? \\nChlordiazepoxide hydrochloride and clidinium ...","Alembic Pharmaceuticals Inc.\\nPOTASSIUM HYDROXIDE\\n (UNII: WZH3C48M4T)\\n \\nPROPYLENE GLYCOL\\n (UNII: 6DC9Q167V3)\\n \\nProduct Characteristics\\nColor\\nGREEN (Light green opaque cap) , GREEN (Light green opaque body)\\nScore\\nno score\\nShape\\nCAPSULE\\nSize\\n16mm\\nFlavor\\nImprint Code\\nA;333\\nContains\\n    \\nPackaging\\n#\\nItem Code\\nPackage Description\\nMarketing Start\\nDate\\nMarketing End\\nDate\\n1\\nNDC:62332-744-\\n31\\n100 \\nin 1 BOTTLE; Type 0: Not a Combination\\nProduct\\n10/04/2023\\n2\\nNDC:62332-744-\\n91\\n1000 \\nin 1 BOTTLE; Type 0: Not ...","CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE -\\nchlordiazepoxide hydrochloride and clidinium bromide capsule \\n \\nAlembic Pharmaceuticals Inc.\\n----------\\nChlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP\\nfor oral use\\nWARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE,\\nMISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL\\nREACTIONS\\n \\nConcomitant use of benzodiazepines and opioids may result in\\nprofound sedation, respiratory depression, coma, and death. Reserve\\nconcomitan...","NYQUIL SEVERE COLD AND FLU- acetaminophen, dextromethorphan hydrobromide,\\ndoxylamine succinate, phenylephrine hydrochloride tablet, coated \\n \\nSavings Distributors LLC\\nDisclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they\\ncomply with applicable regulations and policies. FDA has not evaluated whether this product complies.\\n----------\\nNyQuil Severe Cold &amp; Flu\\nDrug Facts\\nActive ingredients (in each caplet)\\nAcetaminophen 325 mg\\nDextromethorphan HBr 10 m...","Savings Distributors LLC\\n3\\nNDC:73097-009-20\\n40 \\nin 1 CARTON\\n07/08/2019\\n3\\n2 \\nin 1 POUCH; Type 0: Not a Combination Product\\nMarketing Information\\nMarketing Category\\nApplication Number or Monograph Citation\\nMarketing Start Date\\nMarketing End Date\\nOTC monograph final\\npart341\\n07/08/2019\\nLabeler - \\nSavings Distributors LLC \\n(010527359)\\n \\nRevised: 7/2019","ivermectin lotion\\nProduct Information\\nProduct Type\\nHUMAN OTC DRUG\\nItem Code (Source)\\nNDC:0363-4230\\nRoute of Administration\\nTOPICAL\\nActive Ingredient/Active Moiety\\nIngredient Name\\nBasis of Strength\\nStrength\\nIvermectin\\n (UNII: 8883YP2R6D) \\n(Ivermectin - UNII:8883YP2R6D)\\nIvermectin\\n5 mg  in 1 g\\nInactive Ingredients\\nIngredient Name\\nStrength\\nbutylated hydroxyanisole\\n (UNII: REK4960K2U)\\n \\ncastor oil\\n (UNII: D5340Y2I9G)\\n \\ncetyl alcohol\\n (UNII: 936JST6JCN)\\n \\nANHYDROUS CITRIC ACID\\n (UNII: XF417D3PSL)\\n \\nc...","Pregnancy\\n). Instruct patients to inform their healthcare provider if they are pregnant.\\nNursing\\nInstruct patients to notify their healthcare provider if they are breastfeeding or intend to\\nbreastfeed (see \\nPRECAUTIONS, Nursing Mothers\\n).\\nDrug Interactions\\nOpioids\\n \\nThe concomitant use of benzodiazepines, including chlordiazepoxide hydrochloride, a\\ncomponent of chlordiazepoxide hydrochloride and clidinium bromide capsules and\\nopioids increases the risk of respiratory depression because of action...","the maximum recommended human dose of 40 mg/day, based on body surface area)\\nexhibited major skeletal defects.\\nTwo series of reproduction experiments with clidinium bromide were carried out in rats,\\nemploying dosages of 2.5 and 10 mg/kg daily (1.2 and 4.9 times, respectively, the\\nmaximum recommended clinical dose of 20 mg/day, based on body surface area) in\\neach experiment. In the first experiment, clidinium bromide was administered for a 9-\\nweek interval prior to mating; no untoward effect on f...","those who have had longer durations of use.\\nAcute Withdrawal Reactions\\nThe continued use of benzodiazepines, including chlordiazepoxide hydrochloride and\\nclidinium bromide capsules, may lead to clinically significant physical dependence. Abrupt\\ndiscontinuation or rapid dosage reduction of chlordiazepoxide hydrochloride and\\nclidinium bromide capsules after continued use, or administration of flumazenil (a\\nbenzodiazepine antagonist) may precipitate acute withdrawal reactions, which can be\\nlife-thr...","Each chlordiazepoxide hydrochloride and clidinium bromide capsule, USP contains the\\nactive ingredients 5 mg chlordiazepoxide hydrochloride, USP and 2.5 mg clidinium\\nbromide, USP. Each capsule also contains the inactive ingredients lactose monohydrate,\\ncorn starch, talc, titanium dioxide, FD&amp;C Green 3, D&amp;C Yellow 10 and gelatin. The empty\\nhard gelatin capsule shells are printed with edible black ink containing shellac, propylene\\nglycol,  black iron oxide and potassium hydroxide.\\nChlordiazepoxide ...","as the MAO inhibitors and phenothiazines are to be used. The usual precautions in\\ntreating patients with impaired renal or hepatic function should be observed.\\nParadoxical reactions to chlordiazepoxide hydrochloride, e.g., excitement, stimulation\\nand acute rage, have been reported in psychiatric patients and should be watched for\\nduring chlordiazepoxide hydrochloride and clidinium bromide capsules therapy. The\\nusual precautions are indicated when chlordiazepoxide hydrochloride is used in the\\ntre..."]],["color",["#0a980a","#0a980a","#0a980a","#0a980a","#ba0e0e","#ba0e0e","#0a980a","#0a980a","#ba0e0e","#ba0e0e","#0a980a","#0a980a","#0a980a","#0a980a","#0a980a","#ba0e0e","#0a980a","#0a980a","#ba0e0e","#ba0e0e","#0a980a","#0a980a","#0a980a","#0a980a","#ba0e0e"]]]}}},"view":{"type":"object","name":"CDSView","id":"p3981","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p3982"}}},"glyph":{"type":"object","name":"Scatter","id":"p3977","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.7},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.7}}},"nonselection_glyph":{"type":"object","name":"Scatter","id":"p3978","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_alpha":{"type":"value","value":0.1},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.1},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"Scatter","id":"p3979","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"field","field":"color"},"line_alpha":{"type":"value","value":0.2},"line_width":{"type":"value","value":2},"fill_color":{"type":"field","field":"color"},"fill_alpha":{"type":"value","value":0.2},"hatch_color":{"type":"field","field":"color"},"hatch_alpha":{"type":"value","value":0.2}}}}},{"type":"object","name":"GlyphRenderer","id":"p3995","attributes":{"data_source":{"type":"object","name":"ColumnDataSource","id":"p3986","attributes":{"selected":{"type":"object","name":"Selection","id":"p3987","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p3988"},"data":{"type":"map","entries":[["x",{"type":"ndarray","array":{"type":"bytes","data":"duqJQbu+ikFxwohBgYeDQcqse0FanX5BwK6EQQ53h0Est4VBM+6AQUM6e0E5KHNBknuMQTTdkEGoBY5BSoKQQfRslEF9apBB0MmTQSiGmUGXqaZBp1qfQQNeokESJqJBa2apQY4apEFSRalBF2qXQVmGmEH/cZtBisueQVrFpEE="},"shape":[32],"dtype":"float32","order":"little"}],["y",{"type":"ndarray","array":{"type":"bytes","data":"dphtQJa1oUAHFoZAjTQ+QPUcDkC47zpAUuoEQLD8MUBbEphA2WuJQA4MbkDEdEtAbsMrQOoZgUCBLA1ARnxMQFpKLUADwJ5AQbu4QCFqtECJp15AInplQFYBRUCAnp5AvFd+QM7Qh0DaraJAj5SOQAU/ckDeTpdAqx24QAK7tUA="},"shape":[32],"dtype":"float32","order":"little"}]]}}},"view":{"type":"object","name":"CDSView","id":"p3996","attributes":{"filter":{"type":"object","name":"AllIndices","id":"p3997"}}},"glyph":{"type":"object","name":"Scatter","id":"p3992","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"value","value":"grey"},"line_alpha":{"type":"value","value":0.2},"fill_color":{"type":"value","value":"grey"},"fill_alpha":{"type":"value","value":0.2},"hatch_color":{"type":"value","value":"grey"},"hatch_alpha":{"type":"value","value":0.2}}},"nonselection_glyph":{"type":"object","name":"Scatter","id":"p3993","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"value","value":"grey"},"line_alpha":{"type":"value","value":0.1},"fill_color":{"type":"value","value":"grey"},"fill_alpha":{"type":"value","value":0.1},"hatch_color":{"type":"value","value":"grey"},"hatch_alpha":{"type":"value","value":0.1}}},"muted_glyph":{"type":"object","name":"Scatter","id":"p3994","attributes":{"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"size":{"type":"value","value":6},"line_color":{"type":"value","value":"grey"},"line_alpha":{"type":"value","value":0.2},"fill_color":{"type":"value","value":"grey"},"fill_alpha":{"type":"value","value":0.2},"hatch_color":{"type":"value","value":"grey"},"hatch_alpha":{"type":"value","value":0.2}}}}}],"toolbar":{"type":"object","name":"Toolbar","id":"p3949","attributes":{"logo":"grey","tools":[{"type":"object","name":"PanTool","id":"p3964"},{"type":"object","name":"WheelZoomTool","id":"p3965","attributes":{"renderers":"auto"}},{"type":"object","name":"BoxZoomTool","id":"p3966","attributes":{"overlay":{"type":"object","name":"BoxAnnotation","id":"p3967","attributes":{"syncable":false,"level":"overlay","visible":false,"left":{"type":"number","value":"nan"},"right":{"type":"number","value":"nan"},"top":{"type":"number","value":"nan"},"bottom":{"type":"number","value":"nan"},"left_units":"canvas","right_units":"canvas","top_units":"canvas","bottom_units":"canvas","line_color":"black","line_alpha":1.0,"line_width":2,"line_dash":[4,4],"fill_color":"lightgrey","fill_alpha":0.5}}}},{"type":"object","name":"ResetTool","id":"p3972"},{"type":"object","name":"SaveTool","id":"p3973"},{"type":"object","name":"HoverTool","id":"p3940","attributes":{"renderers":[{"id":"p3980"}],"tooltips":"\\n    &lt;div style=\\"width:400px;\\"&gt;\\n    &lt;b&gt;Document id:&lt;/b&gt; @id &lt;br&gt;\\n    &lt;b&gt;Topic:&lt;/b&gt; @topic &lt;br&gt;\\n    &lt;b&gt;Question:&lt;/b&gt; @questions &lt;br&gt;\\n    &lt;b&gt;agent Answer:&lt;/b&gt; @agent_answer &lt;br&gt;\\n    &lt;b&gt;Reference Answer:&lt;/b&gt; @reference_answer &lt;br&gt;\\n    &lt;b&gt;Correctness:&lt;/b&gt; @correctness &lt;br&gt;\\n    &lt;b&gt;Content:&lt;/b&gt; @content\\n    &lt;/div&gt;\\n    "}}]}},"left":[{"type":"object","name":"LinearAxis","id":"p3959","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p3960","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p3961"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p3962"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"below":[{"type":"object","name":"LinearAxis","id":"p3954","attributes":{"ticker":{"type":"object","name":"BasicTicker","id":"p3955","attributes":{"mantissas":[1,2,5]}},"formatter":{"type":"object","name":"BasicTickFormatter","id":"p3956"},"axis_label_standoff":10,"axis_label_text_color":"#E0E0E0","axis_label_text_font":"Helvetica","axis_label_text_font_size":"1.25em","axis_label_text_font_style":"normal","major_label_policy":{"type":"object","name":"AllLabels","id":"p3957"},"major_label_text_color":"#E0E0E0","major_label_text_font":"Helvetica","major_label_text_font_size":"1.025em","axis_line_color":"#E0E0E0","axis_line_alpha":0,"major_tick_line_color":"#E0E0E0","major_tick_line_alpha":0,"minor_tick_line_color":"#E0E0E0","minor_tick_line_alpha":0}}],"center":[{"type":"object","name":"Grid","id":"p3958","attributes":{"axis":{"id":"p3954"},"grid_line_color":"white","grid_line_alpha":0.25}},{"type":"object","name":"Grid","id":"p3963","attributes":{"dimension":1,"axis":{"id":"p3959"},"grid_line_color":"white","grid_line_alpha":0.25}},{"type":"object","name":"Legend","id":"p3983","attributes":{"title":"Question Correctness","title_text_color":"#B1B1B1","title_text_font_style":"bold","border_line_alpha":0,"background_fill_color":"#111516","background_fill_alpha":0.5,"label_text_color":"#E0E0E0","label_text_font":"Helvetica","label_text_font_size":"1.025em","label_standoff":8,"glyph_width":15,"spacing":8,"items":[{"type":"object","name":"LegendItem","id":"p3984","attributes":{"label":{"type":"value","value":"False"},"renderers":[{"id":"p3980"}],"index":4}},{"type":"object","name":"LegendItem","id":"p3985","attributes":{"label":{"type":"value","value":"True"},"renderers":[{"id":"p3980"}],"index":0}}]}},{"type":"object","name":"LabelSet","id":"p4001","attributes":{"level":"glyph","source":{"type":"object","name":"ColumnDataSource","id":"p3998","attributes":{"selected":{"type":"object","name":"Selection","id":"p3999","attributes":{"indices":[],"line_indices":[]}},"selection_policy":{"type":"object","name":"UnionRenderers","id":"p4000"},"data":{"type":"map","entries":[["x",{"type":"ndarray","array":{"type":"bytes","data":"7IyEQZDMnkE="},"shape":[2],"dtype":"float32","order":"little"}],["y",{"type":"ndarray","array":{"type":"bytes","data":"fM5YQOaSk0A="},"shape":[2],"dtype":"float32","order":"little"}],["topic",["Benzodiazepine Risks and Effects","Over-the-Counter and Prescription Drugs"]]]}}},"x":{"type":"field","field":"x"},"y":{"type":"field","field":"y"},"text":{"type":"field","field":"topic"},"text_color":{"type":"value","value":"#B1B1B1"},"text_font_size":{"type":"value","value":"12pt"},"text_font_style":{"type":"value","value":"bold"},"text_align":{"type":"value","value":"center"}}}],"background_fill_color":"#14191B","border_fill_color":"#15191C"}}}}],"tabs_location":"below"}}]}}';
        const render_items = [{"docid":"4589ef04-00b9-4d27-8c90-a9a84be3eb67","roots":{"p4006":"cee0af9c-45a2-476e-a152-6316a3ed6dbc"},"root_ids":["p4006"]}];
        root.Bokeh.embed.embed_items(docs_json, render_items);
        }
        if (root.Bokeh !== undefined) {
          embed_document(root);
        } else {
          let attempts = 0;
          const timer = setInterval(function(root) {
            if (root.Bokeh !== undefined) {
              clearInterval(timer);
              embed_document(root);
            } else {
              attempts++;
              if (attempts > 100) {
                clearInterval(timer);
                console.log("Bokeh: ERROR: Unable to run BokehJS code because BokehJS library is missing");
              }
            }
          }, 10, root)
        }
      })(window);
    });
  };
  if (document.readyState != "loading") fn();
  else document.addEventListener("DOMContentLoaded", fn);
})();
    </script>

                <div id="cee0af9c-45a2-476e-a152-6316a3ed6dbc" data-root-id="p4006" style="display: contents;"></div>
            </div>
        </div>

        <div class="section-container">
            <div class="section-card">

                <div class="section-title">SELECTED METRICS</div>

                

            </div>
        </div>

        
    </div>
</div>



<script type="text/javascript">
    function opentab(evt, name) {
    // Declare all variables
    let i, tabcontent, tablinks;

    // Get all elements with class="tabcontent" and hide them
    tabcontent = document.getElementsByClassName("tabcontent");
    for (i = 0; i < tabcontent.length; i++) {
        tabcontent[i].style.display = "none";
    }

    // Get all elements with class="tablinks" and remove the class "active"
    tablinks = document.getElementsByClassName("tablinks");
    for (i = 0; i < tablinks.length; i++) {
        tablinks[i].className = tablinks[i].className.replace(" active", "");
    }

    // Show the current tab, and add an "active" class to the button that opened the tab
    document.getElementById(name).style.display = "block";
    evt.currentTarget.className += " active";
}
</script>
